- Home
- ABEO vs MIN Comparison
ABEO vs MIN Comparison
Compare ABEO & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABEO | MIN |
|---|---|---|
| Founded | 1974 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.5M | 261.4M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABEO | MIN |
|---|---|---|
| Price | $2.28 | $14.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $18.38 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 33.7K |
| Earning Date | 11-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.31% |
| EPS Growth | ★ 165.16 | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | ★ $2,998,000.00 | N/A |
| Revenue This Year | $731.38 | N/A |
| Revenue Next Year | $129.85 | N/A |
| P/E Ratio | ★ N/A | $176.13 |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $2.30 | $2.27 |
| 52 Week High | $7.65 | $14.39 |
Technical Indicators
Market Signals| Indicator | ABEO | MIN |
|---|---|---|
| Relative Strength Index (RSI) | 17.41 | 84.40 |
| Support Level | N/A | $13.74 |
| Resistance Level | $5.77 | $14.28 |
| Average True Range (ATR) | 0.30 | 0.16 |
| MACD | -0.19 | -0.42 |
| Stochastic Oscillator | 2.26 | 46.15 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About MIN MFS Intermediate Income Trust
Aberdeen Intermediate Income Fund is a diversified, closed-end fixed-income management investment company. The fund's investment objective is to seek high current income, but may also consider capital appreciation.